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Rejection or acceptance by the host of transplated tissues is still the most 
sensitive means by which subtle differences  between individuals of a  species 
can be revealed.  That  available serological  techniques  lag behind  the trans- 
plantation  assay is  witnessed by the  fact that  humoral  antibodies  can  not 
readily be detected in combinations of certain  strains  of mice in which skin 
grafts are promptly rejected, e.g. A anti CBA or C3H and most of the combina- 
tions of mice within one H-2 type (1, 2). Further development of in vitro sero- 
logic methods for the characterization of individuality differentials  may make 
possible the matching  of at least major determinants  between the graft and 
host  for  eventually successful  homografting.  Methods  for  demonstration  of 
antibodies  elicited  by homografts  are  relatively limited  in  scope,  since  the 
antigens  involved have  not  yet been isolated  in  soluble form.  However, an 
extensive body of knowledge about red blood types of inbred strains of mice 
has been accumulated and recently comprehensively reviewed by Amos  (3). 
Antigens revealed by hemagglutination were previously thought to be unrelated 
to transplantation  antigens  (2),  but their  importance in transplantation  has 
become pre-eminent as a consequence of the recent work of Brent, Medawar, 
and Ruszldewicz (4), who found that hemagglutinogens could not be separated 
from cell-free  transplantation  antigens.  Hence, hemagglutinogens  may be tke 
antigens  responsible  for  homograft  immunity.  I-Iistocompatibility  antigens 
could then be assayed by their capacity to absorb hemagglutinating  activity 
(5,  6).  Moreover, hemagglutination  may demonstrate  the  same antigens  re- 
vealed by lymphocyte cytotoxicity tests since ]ensen and Stetson have main- 
mined  that  in the mouse, both types of activities are produced by a  single 
class of antibodies (7). 
The evidence to be presented here suggests certain qualifications  to the above 
conclusions,  (a)  not  a/l  transplantation  antigens  are  hemagglutinogens,  and 
(b) not a/l lymphocyte cytotoxinogens are hemagglutinogens.  Therefore, hemag- 
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glutination does not reveal all transplantation antigens, and lymphocyte cyto- 
toxicity  can  expose  more  of  the  weaker  histocompatibility  antigens  than 
hemagglutination. Minor antigenic differences between 2 closely related strains 
which had led to rejection of skin homografts was not exposed by hemaggluti- 
nation but was  detectable by an improved lymphocyte cytotoxicity reaction. 
Quantitative absorption tests  also indicated that hemagglutination tests may 
fail  to  disclose  heterogeneity  between  graft  and  host  since  erythrocytes  are 
roughly 1000 times less antigenic than lymph node cells. 
Methods 
Aniraals.--Inbrod  mice of the following  strains were  employed: A/Cal,  C57  B1/6  Jax, 
CBA/Jax, and AKR/Jax. 
Imraunization.--Unless otherwise noted, the mice were immunized by 4 to 10 intrapetito- 
neal injections of fresh minced spleen,  thymus, or kidney tissue at 1 to 2 week intervals. 7 
to 14 days after the last injection, the mice were bled from the retro-orbital sinus for antisera. 
ttanagglutinakion.--These tests were performed with slight modifications of the methods 
of Gofer and Mikulska (1) and Stimpling (8). Stock 6 per cent dextran solution in saline of 
average 75,000 MW (Hyland Laboratories, Los Angeles) was diluted for use to 3 per cent in 
pH 7.0 phosphate-bufferod  saline (8). Antlsera were diluted in 0.025 ml of dextran by two- 
fold steps using spiral loop tendrils in plastic trays with small wells of 0.15 ml capacity (9). 
To this was added 0.025 ml of 2 per cent red blood cell suspension (prepared after 2 washings 
in phosphate saline to 10 per cent, then diluted down to 2 per cent with equal volumes of 
phosphate saline and human serum previously heated at 56°C for 30 minutes and absorbed 3 
times with mouse spleen and liver cells). To prevent non-specific clumping in employing these 
small quantifies of fluid, it was found essential to reduce evaporation to a  minimum. This 
was accomplished  by addition of 2 drops of mineral oil to each well. Oil also retarded evapora- 
tion from the wells during the time the cells were being examined and permitted subsequent 
re-examination. Upon 1~ hours' incubation in a shallow water bath at 37°C, the cells were 
streaked on a slide and inspected under dark field illumination. For hemagglutination tests 
by the Stimpling method (8), polyvinyl  pyrrolidone (PVP, type NP-K60, Antara Chemicals, 
New York) was employed at a 0.75 per cent concentration in phosphate saline containing 10 
per cent distilled water. To antibody dilutions made by 0.05 ml volumes in PVP with spiral 
loop tendrils was added 0.025  ml of a  2 per cent suspension of erythrocytes in phosphate 
saline. Following 2 hours' incubation at room temperature the cells were  examined micro- 
scopically as in the dextran test. 
Lymphocyte Cytogoxidty.--All tests were executed in small disposable polyethylene centri- 
fuge tubes of 0.5 ml capacity (Beckman-Spinco, microcentrifuge tubes). To 0.2 ml volumes of 
antisera diluted in Hanks' balanced salt solution, was added 50,000 lymph node cells  (0.01 
ml of a  5  X  108/ml suspension). Lymph node cells were  obtained by teasing out the cells 
with two sharp forceps in Hank's solution, washing once, and suspending in Hanks' solution 
with 10 per cent normal mouse serum. Desiccated guinea pig complement (C  t)  obtained from 
Cappel Laboratories, West Chester, Pennsylvania,  was reconstituted for use in distilled water 
(discarding the diluent containing preservatives supplied by the manufacturer). It was used 
at dilutions of 1:20 to 1:4 depending on the number of days that it was stored (at --50°C) 
and the C t activity as indicated when tested with a standard known antiserum. In tests re- 
quiring high concentrations of mouse antiserum (1:2 to about 1:25) the mouse serum was re- 
moved after 30 minutes' incubation at 37°C before the addition of C I to eliminate its anti- 
complementary effect. With higher antibody dilutions, 0.2 ml of C t was added directly to the PAUL  I.  TERASAKI AND JOHN D.  MCCLELLAND  677 
antibody and cells. Upon incubation for a total of 1 hour in a water bath shaker at 37°C the 
tubes were spun at 15,000 Rp~a in a  microcentrifuge  (Beckman-Spinco)  for 5 seconds. The 
sedimented cells were removed with a fine-tipped pipette onto a dried eosin dot (0.002 ml of 
1 per cent eosin Y), and 200 cells were counted immediately with phase contrast microscopy 
employing a 43 X  objective. The percentage of viable cells was compared to that in the con- 
trol tubes and expressed as the cytotoxic  index: 
C--E  C.I. ffi 
C 
where C -- per cent viable cells in control 
E  -- per cent viable cells in experimental 
RESULTS 
Technical Improvement of  Cytotoxicity Tests: Reduction in Number  of  Cells and 
Removal of the Anticomplementary Ac~on of Mouse Serum.--Sensitivity of the cyto- 
toxicity test (10) was increased by 2 simple modifications. First, with the use of micro- 
centrifuge tubes it was possible to reduce the number of cells to the bare minimum 
necessary to read as one small drop on a  microscope slide (50,000)  (c.f. method of 
Boyse,  Old,  Thomas,  11). 
Second, with weak antibodies, the mouse antiserum was  centrifuged out before 
the addition of complement. Often with weak antisera it was noted that eytotoxicity 
was  not proportional to  the  amount  of antisera added,  and  a  marked  "prozone" 
existed. This effect in which apparently excess antibody may protect against cyto- 
toxicity had made further analysis difficult. It was found that the prozone could be 
diminated by the simple expedient of removing mouse antisera before the addition 
of guinea pig complement as has been mentioned by Amos and Wakefield (12). An 
experiment which demonstrates the effectiveness of this procedure is illustrated in Fig. 
1. An antiserum of strong potency, C57 anti A, was diluted 1:1000,  1:400 and 1:100 
in normal C57 mouse serum to create antisera of graded strengths. Dilutions of this 
artificial antisera were tested with A strain lymph node ceils by simultaneous addition 
of guinea pig C t and incubation for 1 hour (solid line), or incubation for ~/~ hour in 
the mouse antisera, centrifugation and replacement of antisera with C' followed by a 
further  ~  hour's incubation  (dotted line). It can be seen that with an attenuated 
antibody (1 : 1000) if C t was added directly to the murine antisera no cytotoxieity was 
disclosed, whereas a linear cytotoxic effect of the antiserum was revealed if the anti- 
sera was removed before C ~ addition. But if the potency of the antibody was increased 
(1:400 to 1:100), a relatively weaker "prozone" effect was noted. It can thus be con- 
eluded that feeble antibodies at low dilutions can best be shown by removal of the 
antiserum before addition of C ~. The explanation for the "prozone" effect is evident 
from the following experiment in which pre-sensitized ceils (50,000  C57 lymph node 
cells incubated with 0.2 ml of 1 : 100 A anti C57 serum for ~  hour and washed once) 
were added to dilutions of normal mouse serum plus C ~. Murine serum in concentra- 
tions of 1:2 or 1:4 can be seen to protect the already sensitized cells from the action 
of complement (Fig. 2). Thus with C r at a  1:32 dilution, sensitized cells did not lyse 
if high concentrations of normal mouse serum were present. This anticomplementary 
effect of mouse serum however could be reversed by elevated levels of C' (1 : 16, 1:8). x 
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FIG. I. Removal vereu~  non-removal of  mouse antibody. C57 anti  A antibody was diluted 
to 1:1000, 1:400,  or I:I00 in  normal C57 mouse serum to  produce sera  of graded strengths. 
These 3 sera  were then diluted  from a 1:2 dilution,  and incubated with  A  strain  lymph node 
ccUs:  (a) together  with C' for I hour at 37°C (solid  line),  (b) without C' for ~  hour, then 
the mouse antisera  was replaced  with  C'  and incubated for  a further  ~  hour at 37°C (dotted 
line).  Cytotoxic index was determined on this  and the following  graphs  by eosin dye exclu- 
sion as described  in  the methods section. 
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FIG. 2. Anti-C' activity of mouse serum. C57 lymph node cells were sensitized with A anti 
C57 antisera, washed, and added to dilutions of normal mouse serum together with 3 different 
dosage levels of C'. Cytotoxicity was determined following I hour's incubation at 37°C. 
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Since high concentrations of guinea pig serum are often toxic and C' levels are trouble- 
some  to  standardize  accurately,  the  expedience  of  removing  anticomplementary 
mouse serum before addition of C ~  was taken whenever dealing  with low dilutions  of 
antisera  (1:2  to  1:32). 
Corrdation  of Hemagglutinin  Levels  with  Cytotoxin  Levels.--As  shown  in 
Fig.:3, 5 separate pools of A anti CBA spleen sera were cytotoxic in dilutions 
up to  1:512  without  being hemagglutinating.  This lack of hemagglutinating 
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FIG. 4. Effect of allogenic anti-kidney and anti-skin graft sera.  A anti C57 kidney sera and 
C57 anti A skin graft serum were concurrently tested with red blood cells and lymphocytes. 
Scale for coordinates same as in Fig. 3. 
Comparison of hemagglutinating (dextran) ........  and cytotoxic __ __ __ activity. 
activity was confirmed by both the dextran and the PVP methods. It can be 
seen, too, that a  definite, though weaker, discrepancy between the 2 types of 
antibody action was found in the C57 anti A spleen system. Thus at high dilu- 
tions of serum almost all lymph node cells were killed,  whereas erythrocytes 
were not agglutinated. Although such a difference may only express divergence 
in the sensitivity of the 2 techniques (the cytotoxic test employed here used 8 
times  the  volume  of  antibody  used  for  hemagglutination),  with  the  same 
methods,  the antisera produced  in  CBA mice against A  spleen  were equally 
active upon erythrocytes and lymphocytes (Fig.  3).  Antibodies  elicited  in A 
strain mice to  C57  kidney cells fall into the same category of being roughly 
equally  effective in the cytotoxic and hemagglutinating tests (Fig.  4).  On the 
other  hand,  serum from C57  mice grafted with  A  strain  skin was markedly 
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Antibodies to thymic cells were again both hemagglutinating and cytotoxic 
in roughly similar titers in the CBA anti A system but were cytotoxic and not 
hemagglutinating in the reverse A  anti CBA combination  (Fig.  5). Thus the 
unshared determinants present in CBA cells but absent in A  strain mice are 
revealed by the cytotoxicity tests but not by the hemagglutinating methods. 
Anti-thymus antibodies were found to increase with immunization, and remain 
at about the same levels after 4 injections (Fig. 5). 
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I~G. 5. Effect of allogenic anti thymus antisera. A anti CBA and CBA anti A sera were 
tested  for hemagglutinafion and  lymphocyte cytotoxicity. Scales for coordinates same as 
Fig. 3. 
Comparison of cytotoxic activity  __ __ __ with hemagglutinating activity  using PVP 
or dextran-human serum ......... 
* Number of times immunized. 
Between 2 mouse strains of the same H-2  type, definite  cytotoxicity  (C.I. 
=  0.5)  of AKR anti CBA sera were  obtained with 2 serum pools at a  1:256 
dilution. Simultaneous hemagglutination tests with the dextran-hunmn method 
were completely negative from 1: 2 to 1:1024 dilutions after l~z~ and 8 hours of 
incubation. 
Quantitative  Absorption  of  Antibody.--To  demonstrate  any  differential 
absorption of cytotoxic or hemagglutinating  antibodies,  an  antiserum which 
yielded  comparable  hemagglutinin  and  cytotoxic  titers  was  absorbed  with 
graded numbers of erythrocytes or lymph node cells. CBA anti A spleen anti- 
body at a  concentration of 1:16 in 3 per cent dextran-Hanks (6 per cent dex- 682  ANTIBODY  RESPONSE  TO HOMOGRAFTS.  VIII 
tran plus Hanks' balanced salt solution in equal volumes) was added in 0.25 
ml  volumes  to varying numbers  of sedimented  A  line  cells.  After  1 hour's 
absorption  at  37°C,  the  supernatant  fluid  was  tested  for hemagglutinating 
and cytotoxic activity. As evident in Fig. 6, both types of antibody activity 
were removed proportionally by erythrocytes and lymphocytes, indicating no 
preferential absorption.  It  is  noteworthy that  lymphocytes were  about  100 
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FIo. 6. Concurrent absorption of hemagglutinins and cytotoxins. CBA anti A spleen anti- 
serum diluted 1:15 in 3 per cent dextran-Hank.q  was absorbed  in 0.25 ml volumes  with varying 
numbers of sedimented  A strain cells. The supernatant fluid  was assayed  after one hour absorp- 
tion at 37°C for cytotoxidty and hemagglutination by the scale given in Fig. 3. 
times as effective as erythrocytes in removing both cytotoxic and hemaggluti- 
nating activity. 
An  even greater difference in antigenicity between erythrocytes and lym- 
phocytes was apparent with A anti CBA and C57 anti CBA sera. The A anti 
CBA serum was diluted 1:8 in 3 per cent dextran-Hanks for absorption and 
the C57 anti CBA serum was diluted 1:200 in Hank's salt solution. Fig. 7 and 
8 clearly show that with both combinations of sera, approximately 1000 times 
as many red blood cells were required to reduce the toxicity of the serum to a 
level comparable to that produced by lymph node cells. Since the magnitude of 
the difference was  so great,  certain precautions were taken to minimize the 
possibility of contamination of the red blood cell suspensions with leucocytes. 
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FIG. 8. Absorption of lymphotoxins. Aliquots of 0.2 ml of l: 8 A anti CBA spleen antiserum 
in 3 per cent dextran-Hanks  were absorbed  with sedimented CBA cells.  Upon one and 
hour's absorption at 37°C, the superuatant fluid was tested for cytotoxicity with CBA lymph 
node cells. 
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Fio. 9. Absorption of allogenic antisera to kidney tissue. An A anti C57 kidney antiserum 
was diluted 1:50 and added in 0.2 ml aliquots to sedimented C57 cells.  Following ~  hour's 
incubation at 37°C the antiserum was tested for cytotoxic activity with C57 lymph node cells. 
684 
•  I  IIII| 
60  I00 PAUL  I. TERASAKI  AND  JOHN  D. MCCLELLAND  685 
was first spun in an inverted  centrifuge  tube  with  a  rubber  stopper.  Red 
blood cells obtained from the bottom with a  hypodermic needle attached to 
a  syringe were then spun at 1,500 g for 20 minutes in the cold in polyethylene 
tubes  (P.E.  100  to  200)  which were then cut 5  to  10  mm  below the buffy 
coat layer. 
Immunization of  mice  with  allogenic kidney cells  resulted  in  antibodies 
that were cytotoxic to lymph node cells as illustrated by the 7 pools shown in 
ABSORBED WITH: 
......  A STRAIN KIDNEY CELLS 
C  57 STRAIN  KIDNEY CELLS 
~,...,,6..m~O%  %  ....~,~  O'~'O 
0.6 
_z 
0,4 
O,Z 
!  ! 
0  O,,Z  0.4  0.60.8  1.0  2  4  6  6  I0  20  40 
NO.  OF CELLS USED TO ABSORB SERUM X 106  (LOG SCALE) 
FIo. 10. Absorption ol ~ti-klclney serum with Mduey cells. A  anti C57 ]ddney serum at 
1:100 dilutions was absorbed with trypsinized kidney cells for ~  hour at 37°C,  then tested 
with C57 lymph node cells for cytotoxic activity. 
Fig. 4.  This lymphotoxic activity could be absorbed by kidney, spleen, and 
thymic cells  (Fig.  9).  On  a  per  cell  basis,  trypsinized kidney ceils  removed 
lymphotoxic antibodies more readily than spleen or thymic cells.  Absorption 
was strain-specific in that isologons kidney cells did not remove the antibody 
(Fig. 10) 
Attempts  to  dissociate  the  hemagglutinating and  cytotoxic activities  by 
heat at 56°C for different time intervals was unsuccessful. Both activities were 
heat-stable from 5 to 50 minutes at 56°C. 
DISCUSSION 
The  technique of hemagglutination in its present  form  (1,  8)  apparently 
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example of the inadequacy d  the technique  occurs in  the commonly used A 
and  CBA strains of mice. Although reciprocal skin homografts  between these 
strains are sloughed rapidly in about 11 days (13),  hemagglutinins  are found 
only in the CBA mouse against A strain, but not in the reverse combination (2). 
The present work confirmed the finding  that A anti CBA serum is non-hemag- 
glutinating  with either the dextran-human  serum method  or the PVP method. 
Thus hemagglutination  assays, though they measure  the more important  H-2 
antigens, are incapable of detecting all the antigens against which a homograft 
reaction is directed.  On the other hand,  it has  been possible to show that  a 
serologic response of A  strain  mice against  CBA homografts  can  be demon- 
st.rated  if lymphocytes are  used as  the  target  cell.  With  an  improved  cyto- 
toxicity test, A anti CBA sera were shown here to be cytotoxic to a 1:512 dilu- 
tion without being hemagglutinating  (Figs. 3, 5). Parallel results were obtained 
with  two mouse strains  of the same H-2 K  type. AKR anti  CBA sera were 
cytotoxic at a  1:256 dilution, but completely non-hemagglutinating.  Evidence 
that  leucocytes possess more allogenic antigens  than  erythrocytes is also evi- 
dent in the earlier work of Amos (14) and Amos and associates (15). 
With regard to the question of identity of cytotoxinogens with transplanta- 
tion antigens conclusive evidence is lacking, though cytotoxins can be absorbed 
by various  presumably  antigenic  subcellular fractions  (16).  The  assumption 
that cytotoxinogens are identical or similar to hemagglutinogens in the mouse 
is suggested by Jenson and Stetson's finding that one type of antibody is re- 
sponsible for both  the  hemagglutinating  and  cytotoxic activity  of allogenic 
mouse antisera (7). Three lines of evidence were presented: (a) with 60 samples 
of sera, the titers of hemagglutination  and cytotoxicity were consistently cor- 
related,  (b)  cytotoxic activity  could  be  absorbed  by erythrocytes,  and  (v), 
the 2 activities  could not be separated  electrophoretically.  This general  con- 
clusion was further  supported  by MOiler and  Mtiller's finding  that  cytotoxic 
sensitivity  of  tumor  cells  closely  paralleled  their  ability  to  absorb  hemag- 
glutinins  (17). 
The results described here indicate, however, that  although allogenic mouse 
antibodies  may be  both  cytotoxic and  hemagglutinating,  certain  antibodies 
are  cytotoxic without  being  hemagglutinating.  Contrary  to  the  close corre- 
spondence  in  the  hemagglutinin  and  cytotoxin titers  found with  the  Balb/c 
and  C57/B1  mice  (7),  many instances  in  which  the  titer of cytotoxins were 
more than 100 to 500 times greater than the titers of hemagglutinins were noted 
with  other  mouse strains.  Apparently  the  strain  involved  is  a  more  critical 
factor than the particular  tissue used to immunize.  A anti CBA sera  prepared 
against splenic cells or thymic cells (relatively free of erythrocytes)  were both 
lymphotoxic, without being hemagglutinating,  whereas  CBA anti A spleen or 
thymus produced both effects in about equal titers  (Figs. 3, 5). These results PAUL  I.  TERASAKI  AND  ~OIIN  D.  McCLELLAND  687 
also argue against the possibility that relative sensitivity of the 2 tests accounts 
for the difference  in titers since  close correspondence of titers were shown in 
certain strain combinations, but not in others. 
Although the findings of Jensen and Stetson (7) that erythrocytes were able 
to absorb cytotoxins was confirmed,  it was also shown that an extremely dis- 
proportionate number of erythrocytes were needed. Despite the use of dextran 
in  the  absorbing  media  (7),  1000 erythrocytes  were  needed  to  absorb 
the quantity of antibody absorbed by one lymphocyte in the A anti CBA com- 
bination--similarly,  100 erythrocytes to one lymphocyte in the CBA anti  A 
system  (Figs.  8,  6).  Using  another  antibody,  C57  anti  CBA,  again 
approximately 1000 times as many erythrocytes were needed when absorption 
was carried out in Hank's solution (Fig. 7). Thus variability can be shown with 
different strains and different media, but the magnitude of variance in anti- 
genic content of the 2 types of cells is  obvious. Contamination of the erythro- 
cyte suspension with leucocytes may account for some of the absorptive power 
of high numbers of erythrocytes, though smears have revealed contamination 
of less than one per 10,000 cells. Considerations of the surface area available, 
as have been emphasized by the work of M611er and M611er (17) do not apply 
here, for surface area difference of the 2 cell types is inappreciable. In addition, 
correlation of cytotoxic sensitivity of cells to their capacity to absorb hemag- 
glutinins  apparently also are not applicable to their capacity to absorb lym- 
photoxins  since thymic and  splenic  cells  were found  to  absorb lymphotoxic 
antibodies as well as lymph node cells on a per cell basis (Fig.  9), despite the 
fact that thymic ceils are presumably less susceptible to the action of cytotoxic 
antibodies (18). Dissociated kidney cells also were capable of absorbing anti- 
bodies in  relatively small  numbers  (Fig.  9,  10),  though  preliminary  results 
indicate they are less sensitive than lymphocytes to the toxic effect of antibody 
and C'. 
In summary, the present results suggest that allogenic antigens are present 
in immensely greater quantities on lymphocytes than erythrocytes, and that 
this may explain  the ease with which cytotoxic activity with certain sera can 
be demonstrated in the absence of hemagglutinating activity. Some indication 
that there are no qualitative difference in antigenic content between lympho- 
cytes and red blood cells is suggested by the absorption of cytotoxins by eryth- 
rocytes from the critical A anti CBA antisera which itself was non-hemaggluti- 
hating (Fig. 8). 
Although it appears from the foregoing that all transplantation antigens are 
not hemagglutinogens,  it is also of considerable practical importance to deter- 
mine if the converse is true, that is, whether all hemagglutinogens  function as 
histocompatibility determinants.  In the mouse, there is strong evidence that 
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histocompatibility types within which tumors of various kinds can be freely 
transplanted (3,  19, 20).  From such extensive experiments and the findings of 
Brent,  Medawar,  and  Ruskiewicz  (4),  the  inference that  mouse  isohemag- 
glutinogens are actually transplantation antigens would seem justifiable. That 
the blood group antigens of man may play a  similar role has been generally 
discounted since close matching of blood groups for as many as 12 factors (see 
Woodruff and Allan, 21) has been of no avail in successful skin homografting. 
Though it would appear from this that hemagglutinogens in man are not strong 
histocompatibility determinants, it  may be  of importance to  note that  the 
homogr~ft reaction can act with equal rapidity upon "weak" as well as "strong" 
antigens, and a matching of the major determinants does not necessarily pro- 
duce a  readily detectable prolongation in graft survival. Thus, many mice of 
the same blood group  (H-2 type) rapidly reject reciprocal grafts: the intensity 
of the reaction being determined by other "weak" antigens. Whether some of 
the known blood groups of man are the major determinants as are the mouse 
hemagglutinogens remain to be determined. Some red blood cell factors cer- 
tainly may be inconsequential to histocompatibility, and in the rabbit, appar- 
ently  certain  known  hemagglutinogens  are  weak  transplantation  antigens 
whereas cytotoxinogens may function as the major histocompatibility deter- 
minants (Kapitchnikov, Ballantyne, and Stetson, 22). 
SU~M4.RY 
Antigenic differences between certain  inbred  strains  of mice which could 
not  be  revealed  by hemagglutination techniques  were  readily disclosed  by 
lymphocyte cytotoxicity. With  an  improved  cytotoxicity test  lymphotoxic 
titers were as high as 1:512 with non-hemagglutinating A anti CBA antisera. 
In other mouse strain combinations, a close parallel of both types of antibody 
activity was  obtained.  Though both  activities  were absorbed  from antisera 
proportionally by erythrocytes and lymph node cells,  100  to  1000 times as 
many erythrocytes as lymphocytes were necessary to produce an equivalent 
reduction in antibody activity These findings suggest that erythrocytes may 
possess  only subthreshold quantities of certain antigens which are present in 
readily detectable levels on lymphocytes. Lymphocyte cytotoxicity therefore 
may assay a  wider range of allogenic antigens than hemagglutination. 
We wish to express our appreciation for the excellent technical  assistance rendered by Mr. 
Norman E. Rich and Mr. Michael  Mandell, and for the helpful editorial assistance given  us by 
Mrs. Marilyn Fargas. 
BIBLIOGRAPHY 
1.  Gorer, P. A., and Mikulska, Z. B., The antibody response to tumor inoculation. 
Improved methods of antibody detection,  Cancer Research, 1954, 14, 651. 
2.  Hildemann, W. H., and Medawar, P. B., Relationship between skin transplanta- PAUL I.  TERASAKI AND  JOHN D.  McCLELLAND  689 
tion immunity and the formation of humoral isoantibodies in mice, Immunology, 
1959, 2,  44. 
3.  Amos, D. B., Isoantigens of mouse red cells, Ann. New York Acad. Sc.,  1962, 
97,  69. 
4.  Brent, L., Medawar,  P.  B.,  and Ruszkiewicz,  M.,  Serological methods in  the 
study of transplantation antigens, Brit. Y. Exp. Path., 1961, 42,464. 
5.  Davies, D. A. L., and Hutchinson, A. M., The serological determination of histo- 
compatibility activity, Brit. Y. Exp. Path., 1961, 42,587. 
6.  Herzenberg, L. A., and Herzenberg, L. A., Association of H-2 antigens with the 
cell membrane fraction of mouse liver, Proc. Nat. Acad. So., 1961, 47, 762. 
7. Jensen, E., and Stetson, C. A., Humoral aspects of the immune response to homo- 
grafts.  II. Relationship between the hemagglutinating and cytotoxic activities 
of certain isoimmune  sera, Y. Exp. Med.,  1961, 118, 785. 
8.  Stimpfling, J. H., The use of PVP as a developing agent in mouse hemagglutina- 
tion tests,  Transpla~.  Bull., 1961, 9.7, 109. 
9.  Tak£tsy, G., Furesz, J., and Farkas, E., Studies on the quantitative relationships 
of influenza virus--antibody union by means of a simple antibody absorption 
test, Acta Physiol., 1954, 5, 241. 
10.  Terasaki, P.  I., McClelland,  J.  D.,  Cannon,  J. A.,  and Longmire,  W.  P., Jr., 
Antibody response to homografts.  VII. The role of complement in eytotoxieity 
of serum from homografted rabbits, Y. Immunol.,  1961, 8"/, 39. 
11.  Boyse, E. A., Old, L. J., and Thomas, G., A report on some observations  with a 
simplified cytotoxic test, Transplant. Bull., 1962, 29, 63. 
12.  Amos, D. B., and Wakefield, J. D., Detection of cytotoxic iso-antibodies,  Proc. 
Am. Assoc. Cancer Research, 1961, 8, 204. 
13.  Billingham, R. E., Brent, L., Medawar, P. B., and Sparrow, E. M., Quantitative 
studies  on  tissue  transplantation  immunity.  I.  The  survival  times  of  skin 
homografts exchanged  between members of different inbred strains of mice, 
Proc. Roy. Soc. London, Series B., 1954, 148, 43. 
14.  Amos, D. B., The agglutination of mouse leucocytes by iso-immune sera, Brit. Y. 
Exp. Path., 1953, 34, 464. 
15.  Amos, D. B., Corer, P. A., Mikulska,  Z. B., Billingham,  R.  E., and  Sparrow, 
E. M., An antibody response to skin homografts in mice, Brit. Y. Exp. Path., 
1954, 85, 203. 
16.  Basch, R. S., and Stetson, C. A., The relationship between hemagglutinogens  and 
histocompafibility antigens  in  the  mouse,  Ann.  New  York  Acad. So., 1962, 
97, 83. 
17. Mi~ller, E., and Mi~ller, G., Quantitative studies of the sensitivity of normal and 
neoplastic mouse  cells to  the  cytotoxic action of antibodies,  J.  Exp.  Med., 
1962, 115,  527. 
18.  Winn,  H. J.,  The immune response  and  the homograft reaction, Nat.  Cancer 
Inst. Monograph, 1960, 2, 113. 
19.  Snell, G. D., Russell, E., Fekete, E., and Smith, P., Resistance  of various inbred 
strains of mice to tumor homoiotransplants and its relation to the H-2 allele 
which each carries, Y. Nat. Cancer Inst., 1953, 14, 485. 690  ANTIBODY RESPONSE TO  HOMOGRAFTS, VIII 
20.  Counce, S., Smith, P., Barth, R., and Snell,  G. D., Strong and weak histocompati- 
bility gene differences in mice and  their role in  the rejection of homografts of 
tumors and skin, Ann. Surg.,  1956, 1449 198. 
21.  Woodruff, M. F. A., and Allan, T. M., Blood groups and the homograft problem, 
Brit. J. Plastic Surg.,  1953, 5, 238. 
22.  Kaptichnikov, M. M., Ballantyne, D. L., and Stetson, C. A., Immunological reac- 
tions to skin homotransplantation  in rabbits and  rats,  Ann. New York Acad. 
$6.,  1962,  99,  497. 